Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The arginine methyltransferase PRMT2 binds RB and regulates E2F function.

Takanobu Yoshimoto1, Manfred Boehm, Michelle Olive

  • 1Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, 31 Center Dr., 31/5A48, Bethesda, MD 20892, USA.

Experimental Cell Research
|April 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinal Vessel Dysfunction in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: An Ultra-Widefield Fluorescein Angiography Study.

Neurology open access·2026
Same author

mRNA therapy improves the composition and motility in CCDC40-deficient cilia in vitro and in vivo.

American journal of respiratory cell and molecular biology·2026
Same author

Longitudinal <i>in vivo</i> human wound healing model defines key role for smooth muscle cells in ECM remodeling.

bioRxiv : the preprint server for biology·2026
Same author

STING-STAT3-SOX18 Axis Drives EndMT and Epigenetic Reprogramming in SAVI Lung Fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Allograft and recipient tissue injury during cardiac allograft rejection: Evidence from cell-free DNA.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Development and Validation of a Urinary Exosomal miRNA Diagnostic Panel for Early Detection of Esophageal Cancer.

Cancer science·2026
Same journal

The AP2α/PDHA1 signaling pathway promotes lung cancer progression by mediating aerobic glycolysis and inhibiting cuproptosis.

Experimental cell research·2026
Same journal

Distributed transcription activity in DLX proteins defies conventional mapping of a transcription activation domain.

Experimental cell research·2026
Same journal

Extracellular release of cytotoxic aggregates from HSV-1-replicating SH-SY5Y cells: involvement of alpha-synuclein and poly-ubiquitin conjugates.

Experimental cell research·2026
Same journal

MiR-1281 downregulates LMX1B to inhibit gastric cancer development.

Experimental cell research·2026
Same journal

Corrigendum to "Heat shock protein 90β stabilizes focal adhesion kinase and enhances cell migration and invasion in breast cancer cells" [Exp. Cell Res., 326, 1, 1 August 2014, Pages 78-89].

Experimental cell research·2026
Same journal

Neutrophilic differentiation of promyelocytic HL-60 cells is associated with increased expression of terminal galactose residues on the cell surface.

Experimental cell research·2026
See all related articles

Protein arginine methyltransferase 2 (PRMT2) regulates E2F activity by interacting with the retinoblastoma protein (RB). Ablating PRMT2 in mice increases E2F activity and promotes cell cycle progression, revealing a novel regulatory mechanism.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Epigenetics

Background:

  • The retinoblastoma protein (RB) is a key regulator of E2F transcription factors.
  • RB recruits various co-repressors, including histone deacetylases (HDACs), SWI/SNF complex, SUV39H1, and DNMT1, to inhibit E2F activity.
  • The role of protein arginine methyltransferases (PRMTs) in RB-mediated E2F regulation is not fully understood.

Purpose of the Study:

  • To investigate the interaction between PRMT2 and RB in the context of E2F activity regulation.
  • To elucidate the functional consequences of PRMT2 ablation on E2F-dependent gene expression and cell cycle progression.

Main Methods:

  • Co-immunoprecipitation assays to demonstrate the interaction between PRMT2 and RB.
  • Reporter assays to assess PRMT2's effect on E2F1 transcriptional activity.

Related Experiment Videos

  • Gene targeting to create PRMT2-deficient mouse embryonic fibroblasts (MEFs).
  • Analysis of cell cycle progression in PRMT2(-/-) MEFs and vascular tissues.

    • Main Results:

    • PRMT2 directly binds to RB via its AdoMet binding domain.
    • PRMT2 represses E2F1 transcriptional activity in an RB-dependent manner and forms a ternary complex with E2F1 and RB.
    • PRMT2(-/-) MEFs exhibit elevated E2F activity and premature S phase entry after serum starvation.
    • PRMT2 deficiency leads to arterial hyperplastic responses following vascular injury, indicative of enhanced G1-S phase progression.

    Conclusions:

    • PRMT2 is a novel component of the RB-mediated repression complex that regulates E2F activity.
    • PRMT2 plays a critical role in controlling cell cycle progression at the G1-S phase transition.
    • These findings reveal a new epigenetic mechanism involving PRMT2 in the regulation of E2F-dependent cellular processes.